DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical ...
New HIV studies presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) highlight critical evidence gaps that must be addressed to improve HIV treatment ...
Legit.ng on MSN
WHO mentions injection that can prevent Nigerians from getting HIV, doctor release price
WHO issued guidelines on July 14, 2025, recommending twice-yearly lenacapavir injections for HIV prevention, raising urgent questions for Nigeria’s response.
Phase 3 trial results show BIC/LEN is noninferior to BIC/FTC/TAF for maintaining virologic suppression in adults with HIV.
Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...
AllAfrica on MSN
New African Research Shapes the Future of HIV Treatment Globally
Failure to adhere to HIV treatment is costing lives The Ndovu Study is strengthening HIV treatment by redefining how treatment failure and drug resistance are detected, managed, and prevented across ...
Nigeria’s approval to locally package a WHO-prequalified HIV rapid diagnostic test (RDT) may appear technical or ...
Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results